Document Detail


Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation.
MedLine Citation:
PMID:  20685246     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Five patients with aggressive acute leukemias who had relapsed after cord blood transplantation were treated with cord blood derived cytokine-induced killer (CIK) cells. These were obtained by ex vivo expansion, using as starting material the washouts of the cord blood units, left over at the end of the transplant. We did not observe any acute or delayed adverse event, and observed 1 partial response in 1 patient concomitantly with the development of acute grade III graft-versus-host disease (GVHD). These observations show the relatively low toxicity of cord blood-derived CIK cells and, more importantly, the feasibility of this immunotherapy program for patients who could not otherwise benefit from donor lymphocyte infusions.
Authors:
Martino Introna; Alice Pievani; Gianmaria Borleri; Chiara Capelli; Alessandra Algarotti; Caterina Micò; Anna Grassi; Elena Oldani; Josée Golay; Alessandro Rambaldi
Related Documents :
7542576 - High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (ifn...
19581836 - Amino terminal pro b-type natriuretic peptide levels are elevated in the cord blood of ...
15711036 - Potential substitution of cord blood for infant blood in the neonatal sepsis evaluation.
14672566 - Oscillometric assessment of airway obstruction in a mechanical model of vocal cord dysf...
1611016 - Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humor...
10146366 - The proposed use of a 'screening test' to assess oxygenator performance.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-01
Journal Detail:
Title:  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation     Volume:  16     ISSN:  1523-6536     ISO Abbreviation:  Biol. Blood Marrow Transplant.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9600628     Medline TA:  Biol Blood Marrow Transplant     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1603-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Affiliation:
USC Hematology, Ospedali Riuniti Bergamo, Italy. mintrona@ospedaliriuniti.bergamo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytotoxic polyphenols against breast tumor cell in Smilax china L.
Next Document:  Nitrile hydratases (NHases): at the interface of academia and industry.